))
The future of oxygen saturation monitoring with Rob Pupelis
Manage episode 424021843 series 3095917
Content provided by Eoin Walker. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eoin Walker or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Join me as I speak with Rob Pupelis, CEO of Spectros Medical Devices, about the latest advancements in tissue oximetry and the future of this medical technology. Rob is a leader in the development of non-invasive sensing and remote monitoring in healthcare, with a focus on shedding light on tissue health and diseases related to vascular performance.
During our discussion, we cover a range of topics, including Rob's background and involvement in this area of innovation, the current problems and leverage points in the industry, and how modern clinical practice informs future priorities regarding tissue oximetry monitoring. We also delve into Rob's innovations within tissue oximetry and how they might advance clinical and critical care, as well as the results and themes that emerged in the data when looking at tissue oxygenation.
Rob also unpacks the T-Stat Tissue Oximeter and explains why it is both more sensitive and real-time in its readings. We explore the main domains of medicine served by Spectros Medical Devices and how they could impact critical care transfers and high acuity transfers in pre-hospital care. Finally, Rob shares some take-home points that he advocates in regard to tissue oximetry monitoring. Don't miss out on this insightful conversation about the future of medical technology. To find out more about the T-Sat Tissue Oximeter see here:
192 episodes
Share
